Alnylam Pharmaceuticals, Inc. (BMV:ALNY)

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,118,291	632,425	406,090	570,313	415,790	300,466
Market Cap Growth	45.68%	55.73%	-28.79%	37.16%	38.38%	24.07%
Enterprise Value	1,119,195	631,299	410,448	576,677	407,412	291,285
Last Close Price	8380.00	4900.00	3227.45	4682.29	3880.27	2750.00
PS Ratio	18.99	13.50	13.14	28.18	24.02	30.64
PB Ratio	260.67	452.40	-108.87	-184.79	34.48	14.86
P/TBV Ratio	260.67	452.40	-	-	34.48	14.86
P/FCF Ratio	275.42	-	572.67	-	-	-
P/OCF Ratio	229.32	-	230.62	-	-	-
EV/Sales Ratio	18.78	13.48	13.28	28.50	23.54	29.70
EV/FCF Ratio	275.64	-	578.81	-	-	-
Debt / Equity Ratio	11.86	40.89	-12.16	-16.51	3.72	1.57
Debt / FCF Ratio	12.53	-	63.96	-	-	-
Asset Turnover	0.71	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	6.83	3.86	2.85	1.57	1.74	1.19
Quick Ratio	2.37	2.61	2.86	3.17	3.79	4.23
Current Ratio	2.54	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	32.73%	-	-	-526.14%	-106.31%	-69.92%
Return on Assets (ROA)	3.65%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%
Return on Capital (ROIC)	5.74%	-4.19%	-7.17%	-18.77%	-16.46%	-23.80%
Earnings Yield	0.07%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%
FCF Yield	0.36%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%
Buyback Yield / Dilution	-4.82%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.